Imaging of liver cancer.
Improvements in imaging technology allow exploitation of the dual blood supply of the liver to aid in the identification and characterisation of both malignant and benign liver lesions. Imaging techniques available include contrast enhanced ultrasound, computed tomography and magnetic resonance imaging. This review discusses the application of several imaging techniques in the diagnosis and staging of both hepatocellular carcinoma and cholangiocarcinoma and outlines certain characteristics of benign liver lesions. The advantages of each imaging technique are highlighted, while underscoring the potential pitfalls and limitations of each imaging modality.
Ariff
Ben
B
Department of Imaging, Imperial College Healthcare NHS Trust, Charing Cross Hospital Campus, Fulham Palace Road, London W6 8RF, United Kingdom.
Lloyd
Claire R
CR
Khan
Sameer
S
Shariff
Mohamed
M
Thillainayagam
Andrew V
AV
Bansi
Devinder S
DS
Khan
Shahid A
SA
Taylor-Robinson
Simon D
SD
Lim
Adrian K P
AK
D018281:Cholangiocarcinoma / Q000000981:diagnostic imaging / Q000473:pathology*; D003287:Contrast Media; D022781:Hepatocytes / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000556:secondary; D008279:Magnetic Resonance Imaging; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging / Q000473:pathology; D014057:Tomography, X-Ray Computed / Q000379:methods; D014463:Ultrasonography / Q000009:adverse effects / Q000379:methods
D003287:Contrast Media